Mercy Medical Center has made history as the first hospital in the world to use the newly FDA-approved MarginProbe® 2 during breast-conserving surgery. This technology helps surgeons check tissue during surgery to make sure all cancer is removed. The device confirms whether the edges of the removed tissue are free of cancer, meaning that fewer patients have to return for another surgery, which can ease their stress and speed their recovery. Mercy has used the original MarginProbe since 2014 and

Happy holidays from all of us at HaysMed! Take a moment to enjoy this festive tour of our beautifully lit campus, courtesy of the HaysMed Foundation. While you’re out and about, be sure to drive through and experience the holiday lights in person, you might just spot something new this year! | Hays Medical Center

Mercy Medical Center: Explaining new breakthroughs in chemotherapy treatments for breast cancer

Cancer and Cancer Treatment | Mercy

Careers at UTHealth Houston | UTHealth Houston jobs

Home | Mercy Careers Apply

Careers | Mercy Care Atlanta